Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2378749Generated: October 30, 2026

4-Methylmorpholine → (E)-4-{4-[2-(1H-indazol-3-yl)vinyl]benzoyl}-1-(2-methoxyethyl)piperazin-2-one hydrochloride

https://huagongshe.com/reaction/2378749

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-MethylmorpholineHCID 7972—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
Reactant1-Hydroxybenzotriazole hydrateHCID 2796029—
Reactant(E)-4-(2-(1H-indazol-3-yl)vinyl)benzoic acidHCID 11437002—
Reactant1-(2-Methoxyethyl)piperazin-2-oneHCID 18783904—
ReactantHydrogen chloride-ethyl acetateHCID 21866389—
Product(E)-4-{4-[2-(1H-indazol-3-yl)vinyl]benzoyl}-1-(2-methoxyethyl)piperazin-2-one hydrochlorideHCID 6709069212%

Reaction Steps

The crude product obtained using (E)-4-[2-(1H-indazol-3-yl)vinyl]benzoic acid (50.0 mg, 0.189 mmol) obtained in Step 6 of Example 1, N-methylmorpholine (0.0415 mL, 0.378 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (50.7 mg, 0.265 mmol), 1-hydroxybenzotriazole monohydrate (33.2 mg, 0.246 mmol) and 1-(2-methoxyethyl)piperazin-2-one (44.8 mg, 0.284 mmol) in a similar manner to Step 7 of Example 1, was treated with hydrogen chloride-ethyl acetate solution (4 mol/L, 0.236 mL) to obtain Compound 134 (10.0 mg, 12%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07470717B2
Source datasetuspto-grants-2008_12
ORD IDord-499efd8574c946d286c37d0dd35ae389
Source noteuspto-grants-2008_12